Related Experiment Video
Updated: Nov 12, 2025
Author Spotlight: Advancements in iPSCs and Genetic Disease Research
Published on: October 20, 2023
Inhibition of MTA2 and MTA3 induces mesendoderm specification of human embryonic stem cells
Yu You1, Yandi Cui1, Yuting Li1
1Center for Stem Cell and Translational Medicine, School of Life Sciences, Anhui University, Hefei, 230601, PR China.
Abstract:
Fully understanding the regulatory network under the pluripotency of embryonic stem cells (ESC) is a prerequisite for their safe application. Here, we addressed the characteristics of metastasis-associated (MTA) family members in human ESCs and found that knockdown of the expression of MTA2 and MTA3, but not MTA1, would induce differentiation. High-throughput sequence and quantitative real-time PCR showed that the decreased MTA2 or MTA3 gene transcript mainly led to the emergence of mesendoderm associated markers. Finally, based on the chemical small molecule library screening, we observed that addition of ID8, a specific inhibitor of the dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs), was able to impair the differentiation phenotype induced by MTA2 and MTA3 reduction. Functional assay showed that ID8 could mediate differentiation caused by MTA2 or MTA3 knockdown mainly through inhibition of DYRK4 activity. Therefore, our finding provides the evidence that the functions of MTA family genes in human ESCs are different. Revealing the function of MTA in ESCs with different pluripotency states will help us better understand and apply stem cells.
Insights
Metastasis-associated (MTA) family members MTA2 and MTA3 regulate pluripotency in human embryonic stem cells (ESCs). Inhibiting dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) with ID8 can prevent differentiation caused by MTA2/MTA3 reduction.
Area of Science:
- Stem Cell Biology
- Molecular Regulation
- Epigenetics
Background:
- Understanding the regulatory network governing embryonic stem cell (ESC) pluripotency is crucial for their safe therapeutic applications.
- The metastasis-associated (MTA) gene family's role in ESC pluripotency remains incompletely understood.
Purpose of the Study:
- To investigate the specific functions of MTA family members (MTA1, MTA2, MTA3) in maintaining human ESC pluripotency.
- To identify molecular mechanisms and potential therapeutic targets regulating MTA-mediated pluripotency.
Main Methods:
- Gene knockdown experiments targeting MTA1, MTA2, and MTA3 in human ESCs.
- High-throughput sequencing and quantitative real-time PCR to analyze gene expression changes.
- Chemical small molecule library screening and functional assays using a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor (ID8).
Main Results:
- Knockdown of MTA2 or MTA3, but not MTA1, induced differentiation in human ESCs, characterized by the emergence of mesendoderm markers.
- ID8, a DYRK inhibitor, effectively reversed the differentiation phenotype induced by MTA2/MTA3 knockdown.
- ID8 mediated this effect primarily by inhibiting DYRK4 activity.
Conclusions:
- MTA2 and MTA3 play distinct, essential roles in maintaining human ESC pluripotency, while MTA1 does not.
- DYRK kinases, particularly DYRK4, are involved in the MTA-mediated regulation of ESC differentiation.
- These findings offer insights into stem cell regulation and potential strategies for controlling stem cell fate.
